Roman Campbell

Taking a Closer Look At IO Biotech Inc (IOBT) Following Its Recent Trade

Roman Campbell

IO Biotech Inc’s recently made public that its Director Hunter Heidi acquired Company’s shares for reported $20884.0 on May 30 ...

Investing in Novagold Resources Inc (NG): What You Must Know

Roman Campbell

Novagold Resources Inc’s recent filing unveils that its Director Schutt Ethan acquired Company’s shares for reported $20000.0 on Jul 28 ...

WWW stock rated a Market perform by Telsey Advisory Group

Roman Campbell

In a filing, Wolverine World Wide, Inc revealed its Director Boyle Jack acquired Company’s shares for reported $98562.0 on Nov ...

Match Group Inc (MTCH) gets rating Downgrade from HSBC Securities

Roman Campbell

Match Group Inc’s filing revealed that its Chief Executive Officer Rascoff Spencer M acquired Company’s shares for reported $0.45 million ...

Potential Price Increase for McGraw Hill Inc (MH) After Recent Insider Activity

Roman Campbell

McGraw Hill Inc’s recently made public that its Director REINEMUND STEVEN acquired Company’s shares for reported $0.24 million on Nov ...

Recent Insider Activity Could Benefit Cytokinetics Inc (CYTK)

Roman Campbell

Cytokinetics Inc’s recent filing unveils that its Director PARSHALL B LYNNE unloaded Company’s shares for reported $0.32 million on Nov ...

Haemonetics Corp [HAE] Stock bought by Insider KROLL MARK W for $98784.0

Roman Campbell

In a filing, Haemonetics Corp revealed its Director KROLL MARK W acquired Company’s shares for reported $98784.0 on Nov 10 ...

A Guide To The Risks Of Investing In Compass Therapeutics Inc (CMPX)

Roman Campbell

Compass Therapeutics Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Schuetz Thomas J. acquired Company’s shares for reported $21100.0 on ...

Investing in Roivant Sciences Ltd (ROIV) Is Getting More Attractive

Roman Campbell

Roivant Sciences Ltd’s recently made public that its Director MANCHESTER KEITH S unloaded Company’s shares for reported $26.3 million on ...

Summit Therapeutics Inc’s latest rating changes from various analysts

Roman Campbell

Summit Therapeutics Inc’s recent filing unveils that its Director Xia Yu acquired Company’s shares for reported $10.0 million on Oct ...

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.